CVS Health Corporation
CVS
$65.75
$0.911.40%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.19% | 4.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.19% | 4.45% | |||
| Cost of Revenue | 2.34% | 6.45% | |||
| Gross Profit | 1.13% | -7.55% | |||
| SG&A Expenses | -2.56% | 2.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.79% | 6.02% | |||
| Operating Income | 27.14% | -45.80% | |||
| Income Before Tax | 1,924.76% | -95.51% | |||
| Income Tax Expenses | 1,379.41% | -94.02% | |||
| Earnings from Continuing Operations | 2,185.92% | -95.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 31.25% | 700.00% | |||
| Net Income | 1,789.66% | -95.08% | |||
| EBIT | 27.14% | -45.80% | |||
| EBITDA | 14.74% | -32.04% | |||
| EPS Basic | 1,789.73% | -95.10% | |||
| Normalized Basic EPS | 37.90% | -45.24% | |||
| EPS Diluted | 1,789.73% | -95.10% | |||
| Normalized Diluted EPS | 37.67% | -45.11% | |||
| Average Basic Shares Outstanding | 0.00% | 0.24% | |||
| Average Diluted Shares Outstanding | 0.16% | 0.00% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.95% | 18.85% | |||
